<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35422571</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1986-5961</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medical archives (Sarajevo, Bosnia and Herzegovina)</Title><ISOAbbreviation>Med Arch</ISOAbbreviation></Journal><ArticleTitle>Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 - a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>71</EndPage><MedlinePgn>66-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5455/medarh.2022.76.66-71</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Myalgia reflects generalized inflammation and cytokine response and can be the onset symptom of 36% of patients with COVID-19. Interleukin-6 (IL-6) and tumor necrosis factor-&#x3b1; (TNF- &#x3b1;) levels in plasma and upper respiratory secretions directly correlate with the magnitude of viral replication, fever, and respiratory and systemic symptoms, including musculoskeletal clinical manifestations.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The aim of our work is to report literature scientific investigation clinical protocol to reduce the immunomodulation and inflammatory response nutraceutical therapy associated with dexamethasone and how can reduce the expression of Interlukina-6(IL-6) and myalgia due to COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched in Pubmed and Cochrane the nautriceutical drugs to treat the immune modulation of organism to COVID-19. We put these keywords: immune inflammation, desease descriptions, epidemiology COVID-19; immunomodulations; IL-6; Rheumatic Symptoms; Joint; Musculoskeletal Disorders; dexamethasone; Polydatin; Zinc; Melatonin; N- Acetyl Cysteine; Colostrum; L- Glutamine; Vitamin D3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We found 61 papers. All the authors analyze them. After the Analyze we suggest the use of response nutraceutical therapy associated with dexamethasone can reduce the expression of Interlukina-6(IL-6) and myalgia due to COVID-19.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">According the scientific literature nutraceutical therapy associated with dexamethasone can reduce the expression of Interlukina-6(IL-6) and myalgia due to COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022 Umberto Ripani, Michele Bisaccia, Luigi Meccariello.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ripani</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Pain Therapy Center, Division of Anesthesia, Analgesia and Intensive Care, Department of Emergency, Ospedali Riuniti di Ancona, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisaccia</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Orthopedics and Trauma Surgery, University of Perugia, S. Maria della Misericordia Hospital, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meccariello</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics and Traumatology, Azienda Ospedaliera Gaetano Rummo, Benevento, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Bosnia and Herzegovina</Country><MedlineTA>Med Arch</MedlineTA><NlmUniqueID>101635337</NlmUniqueID><ISSNLinking>0350-199X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">L-Glutammine</Keyword><Keyword MajorTopicYN="N">N-acetyl cysteine</Keyword><Keyword MajorTopicYN="N">colostrum freeze drying</Keyword><Keyword MajorTopicYN="N">covid long haul</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">dexamethasone</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">joint pain</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">melatonin</Keyword><Keyword MajorTopicYN="N">musculoskeletal pain</Keyword><Keyword MajorTopicYN="N">nutraceutical factors</Keyword><Keyword MajorTopicYN="N">polydatin</Keyword><Keyword MajorTopicYN="N">um-PEA</Keyword><Keyword MajorTopicYN="N">vitamin D3</Keyword><Keyword MajorTopicYN="N">zinc</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35422571</ArticleId><ArticleId IdType="pmc">PMC8976893</ArticleId><ArticleId IdType="doi">10.5455/medarh.2022.76.66-71</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carinci F. Covid-19: preparedness, decentralisation, and the hunt for patient zero. BMJ. 2020;368:bmj.m799. doi: 10.1136/bmj.m799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m799</ArticleId><ArticleId IdType="pubmed">32111645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucuk A, Cumhur Cure M, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol. 2020 Jul;39(7):2103&#x2013;2104. doi: 10.1007/s10067-020-05178-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05178-1</ArticleId><ArticleId IdType="pmc">PMC7249985</ArticleId><ArticleId IdType="pubmed">32458242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. Version 2. J Orthop Surg Res. 2020;15(1):178. doi: 10.1186/s13018-020-01702-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-020-01702-w</ArticleId><ArticleId IdType="pmc">PMC7232908</ArticleId><ArticleId IdType="pubmed">32423471</ArticleId></ArticleIdList></Reference><Reference><Citation>Amici C, Di Caro A, Ciucci A, Chiappa L, Castilletti C, Martella V, Decaro N, Buonavoglia C, Capobianchi MR, Santoro MG. Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2006;11(8):1021&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">17302372</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuano A, Scavone C, Racagni G, Scaglione F Italian Society of Pharmacology. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Pharmacol Res. 2020 Jul;157:104849. doi: 10.1016/j.phrs.2020.104849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104849</ArticleId><ArticleId IdType="pmc">PMC7189871</ArticleId><ArticleId IdType="pubmed">32360482</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuano A, Scavone C, Racagni G, Scaglione F Italian Society of Pharmacology. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? The Lancet rheumatology. 2020 doi: 10.1016/j.phrs.2020.104849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104849</ArticleId><ArticleId IdType="pmc">PMC7189871</ArticleId><ArticleId IdType="pubmed">32360482</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh S. How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care. J Educ Eval Health Prof. 2020 Jan;17:10. doi: 10.3352/jeehp.2020.17.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.3352/jeehp.2020.17.10</ArticleId><ArticleId IdType="pmc">PMC7162995</ArticleId><ArticleId IdType="pubmed">32150796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China. J Med Virol. 2020 Mar 13; doi: 10.1002/jmv.25763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25763</ArticleId><ArticleId IdType="pmc">PMC7228360</ArticleId><ArticleId IdType="pubmed">32167181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses&#x2013;drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097181</ArticleId><ArticleId IdType="pubmed">26868298</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF, Lau SK, Woo PC, Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042844</ArticleId><ArticleId IdType="pubmed">32083643</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US &#x2018;hot spot&#x2019;. Ann Rheum Dis. 2020 doi: 10.1136/annrheumdis-2020-217888. annrheumdis-2020-217888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217888</ArticleId><ArticleId IdType="pmc">PMC7456555</ArticleId><ArticleId IdType="pubmed">32457048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110798</ArticleId><ArticleId IdType="pubmed">32007643</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus [2019-nCoV] infected pneumonia [standard version] Mil Med Res. 2020;7:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003341</ArticleId><ArticleId IdType="pubmed">32029004</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravagnan G, De Filippis A, Carten&#xec; M, De Maria S, Cozza V, Petrazzuolo M, et al. Polydatin, a natural precursor of resveratrol, induces &#x3b2;-defensin production and reduces infl ammatory response. Infl ammation. 2013;36(1):26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">22956122</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maria S, Scognamiglio I, Lombardi A, Amodio N, Caraglia M, Carten&#xec; M, et al. Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell. J Transl Med. 2013;11:264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3854516</ArticleId><ArticleId IdType="pubmed">24138806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-infl ammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Infl ammation. 2012;35(1):240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">21369944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Gong X, Mo Y, Wu S. Polydatin inhibits the oxidative stress-induced proliferation of vascular smooth muscle cells by activating the eNOS/SIRT1 pathway. Int J Mol Med. 2016;37(6):1652&#x2013;1660.</Citation><ArticleIdList><ArticleId IdType="pubmed">27081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SC, Ho CT, Chuo WH, Li S, Wang TT, Lin CC. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 2017 Feb 13;17(1):144. doi: 10.1186/s12879-017-2253-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2253-8</ArticleId><ArticleId IdType="pmc">PMC5307780</ArticleId><ArticleId IdType="pubmed">28193191</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y. Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. Eur J Med Chem. 2006 Sep;41(9):1084&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7119042</ArticleId><ArticleId IdType="pubmed">16875760</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrosino S, Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 2017 Jun;174(11):1349&#x2013;1365. doi: 10.1111/bph.13580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13580</ArticleId><ArticleId IdType="pmc">PMC5429331</ArticleId><ArticleId IdType="pubmed">27539936</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, et al. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther. 2008;326:12&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">18367664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestmann ER. Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential. Food Sci Nutr. 2016 doi: 10.1002/fsn3.392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.392</ArticleId><ArticleId IdType="pmc">PMC5332261</ArticleId><ArticleId IdType="pubmed">28265364</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 2020 Feb 27; doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010 Nov 4;6(11):e1001176. doi: 10.1371/journal.ppat.1001176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001176</ArticleId><ArticleId IdType="pmc">PMC2973827</ArticleId><ArticleId IdType="pubmed">21079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Radic Biol Med. 2004;37:1182&#x2013;1190. doi: 10.1016/j.freeradbiomed.2004.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.07.007</ArticleId><ArticleId IdType="pubmed">15451058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao S, Knoell DL. Zinc modulates cytokine-induced lung epithelial cell barrier permeability. Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1132&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16844947</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt J. Melatonin: characteristics, concerns, and prospects. J Biol Rhythm. 2005;20:291&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">16077149</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005;27:189&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">16217132</ArticleId></ArticleIdList></Reference><Reference><Citation>Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011;51:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">21752095</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vico A, Lardone PJ, Alvarez-S&#xe1;nchez N, Rodr&#xed;guez-Rodr&#xed;guez A, Guerrero JM. Melatonin: buffering the immune system. Int J Mol Sci. 2013 Apr 22;14(4):8638&#x2013;8683. doi: 10.3390/ijms14048638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14048638</ArticleId><ArticleId IdType="pmc">PMC3645767</ArticleId><ArticleId IdType="pubmed">23609496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CF, Wang D, Reiter RJ, Yeh DY. Oral melatonin attenuates lung inflammation and airway hyperreactivity induced by inhalation of aerosolized pancreatic fluid in rats. J Pineal Res. 2011;50:46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">20964706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GD, Lee SE, Kim TH, Jin YH, Park YS, Park CS. Melatonin suppresses acrolein-induced il-8 production in human pulmonary fibroblasts. J Pineal Res. 2012;52:356&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">21951103</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SH, Cao XJ, Liu W, Shi XY, Wei W. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J Pineal Res. 2010;48:109&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">20070490</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldeus P, Cotgreave IA, Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration. 1986;50(Suppl 1):31&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">3809741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y, Zhu Y, Wen T, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis. 2013;208:1962&#x2013;1967.</Citation><ArticleIdList><ArticleId IdType="pubmed">23990573</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Wang D, Gao R, Zhao B, et al. Biological features of novel avian influenza A (H7N9) virus. Nature. 2013;499:500&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">23823727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mata M, Morcillo E, Gimeno C, Cortijo J. N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV) Biochem Pharmacol. 2011;82:548&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">21635874</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol. 2004;85:2347&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pubmed">15269376</ArticleId></ArticleIdList></Reference><Reference><Citation>Decaro N, Elia G, Campolo M, et al. Detectionof Bovine coronavirus using a TaqMan-based real-time RT-PCRassay. J Virol Methods. 2008;151:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112840</ArticleId><ArticleId IdType="pubmed">18579223</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark MA. Bovine coronavirus. Br Vet J. 1993;149:51&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130254</ArticleId><ArticleId IdType="pubmed">8382546</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai MMC, Perlman S, Anderson LJ. Coronaviridae. In: Fields B, Knipe N, David M, Howley P, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 5th. Philadelphia: Wolters Kluwer Health/LippincottWilliams &amp; Wilkins; 2007. pp. 1305&#x2013;1335.</Citation></Reference><Reference><Citation>Bok M, Alassia M, Frank F, et al. Passive immunity to control Bovine coronavirus diarrhea in a dairy herd in Argentina. Rev Argent Microbiol. 2018 Jan-Mar;50(1):23&#x2013;30. doi: 10.1016/j.ram.2017.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ram.2017.03.007</ArticleId><ArticleId IdType="pmc">PMC7116951</ArticleId><ArticleId IdType="pubmed">28893529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248798</ArticleId><ArticleId IdType="pubmed">22195744</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr EL, et al. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol. 2010;185(2):1037&#x2013;1044. doi: 10.4049/jimmunol.0903586.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903586</ArticleId><ArticleId IdType="pmc">PMC2897897</ArticleId><ArticleId IdType="pubmed">20554958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol. 2013;14(5):500&#x2013;508. doi: 10.1038/ni.2556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2556</ArticleId><ArticleId IdType="pmc">PMC3672957</ArticleId><ArticleId IdType="pubmed">23525088</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CJ, Ou YC, Chang CY, et al. Glutamate released by Japanese encephalitis virus-infected microgl&#xed;a involves TNF-alpha signaling and contributes to neuronal death. Glia. 2012;60:487&#x2013;501. doi: 10.1002/glia.22282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22282</ArticleId><ArticleId IdType="pubmed">22144112</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitamin D and Health: Scientific Advisory Committee on Nutrition. 2016.  
 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf
.</Citation></Reference><Reference><Citation>Amrein K, Quraishi SA, Litonjua AA, et al. Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: A cohort study. J Clin Endocrinol Metab. 2014;99:1461&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3973775</ArticleId><ArticleId IdType="pubmed">24423347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909&#x2013;2912.</Citation><ArticleIdList><ArticleId IdType="pubmed">15322146</ArticleId></ArticleIdList></Reference><Reference><Citation>White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J. Steroid Biochem. Mol Biol. 2010;121:234&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">20302931</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonstra A, Barrat FJ, Crain C. et. al. 1alpha, 25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974&#x2013;4980.</Citation><ArticleIdList><ArticleId IdType="pubmed">11673504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawaz L, Mrad MF, Kazan JM, et al. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation. Clin Immunol. 2016;166:59&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">27041081</ArticleId></ArticleIdList></Reference><Reference><Citation>Korf H, Wenes M, Stijlemans B, et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 2012;217:1292&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pubmed">22944250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghayda RA, Lee KH, Han YJ, Ryu S, Hong SH, Yoon S, Jeong GH, et al. Global case fatality rate of coronavirus disease 2019 (COVID-19) by continents and national income: a meta-analysis. J Med Virol. 2022 Jan 31; doi: 10.1002/jmv.27610. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27610</ArticleId><ArticleId IdType="pmc">PMC9015248</ArticleId><ArticleId IdType="pubmed">35099819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zildzic M, Masic I. The Importance of Nutrition in Boosting Immunity for Prevention and Treatment COVID-19. Bosnia and Herzegovina Experiences related to the COVID-19 Pandemic. Int J Biomed Healthc. 2020 Dec;8:118&#x2013;119.</Citation></Reference><Reference><Citation>Salihefendic Dz, Zildzic M, Masic I. The Importance of the Quantity and the Distribution Assessment of Fat Tissue in a Diagnosis of Insulin Resistance. Med Arch. 2020 Dec;74(6):439&#x2013;443. doi: 10.5455/medarh.2020.74.439-443.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/medarh.2020.74.439-443</ArticleId><ArticleId IdType="pmc">PMC7879345</ArticleId><ArticleId IdType="pubmed">33603268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>